Navitas, Cyient Semiconductors Enter into a Strategic Partnership to Accelerate GaN Adoption in India’s AI, Mobility, Industrial, and Energy Markets

Navitas, Cyient Semiconductors Enter into a Strategic Partnership to Accelerate GaN Adoption in India's AI, Mobility, Industrial, and Energy Markets GlobeNewswire December 08, 2025 TORRANCE, Calif. and HYDERABAD, India, Dec. 08, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor Corporation (Nasdaq: NVTS), the industry leader in next-generation GaNFast(TM) gallium nitride (GaN) and GeneSiC(TM) silicon carbide (SiC) power […]

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

IRADIMED Announces Special Cash Dividend of $0.50 Per Share GlobeNewswire December 08, 2025 ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) — iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50 per share of the Company's outstanding common stock. This special cash dividend is

iAnthus Continues Expansion in Florida with the Opening of GrowHealthy’s 25th Dispensary in St. Petersburg

iAnthus Continues Expansion in Florida with the Opening of GrowHealthy's 25th Dispensary in St. Petersburg Dispensary Opening Brings Expanded Access to Premium Products, Introduces New Brands and Delivers an Elevated Patient Experience GlobeNewswire December 08, 2025 NEW YORK and TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE:

Virco Reports Loss of $1.3 Million in Third Quarter as Cyclical Decline Begins to Slow

Virco Reports Loss of $1.3 Million in Third Quarter as Cyclical Decline Begins to Slow GlobeNewswire December 08, 2025 Revenue through Nine Months Down 27.0% to $173.5 Million Net Income through Nine Months is $9.6 Million Key Balance Sheet Metrics Continue to Improve as Current Ratio Reaches 3.98 Backlog Pulls Nearly Even on YOY Basis

Orion to Participate in Singular Research’s 19th Annual Best of the Uncovereds Conference on December 11, 2025

Orion to Participate in Singular Research's 19th Annual Best of the Uncovereds Conference on December 11, 2025 GlobeNewswire December 08, 2025 MANITOWOC, Wis., Dec. 08, 2025 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced that

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic malignancies GlobeNewswire December 08, 2025 CAMBRIDGE, Mass.,

American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Additional Expansion of Pennsylvania Distribution Footprint for American Rebel Light Beer with Banko Beverage Company

American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Additional Expansion of Pennsylvania Distribution Footprint for American Rebel Light Beer with Banko Beverage Company GlobeNewswire December 08, 2025 Banko Beverage Company (PA) is family-owned wholesaler with 90+ year legacy, MillerCoors President's Award recognition, and 10-county footprint servicing the Greater Lehigh Valley for American Rebel Light Beer Banko

Data Storage Corporation Announces Its Intention to Commence a Tender Offer

Data Storage Corporation Announces Its Intention to Commence a Tender Offer GlobeNewswire December 08, 2025 MELVILLE, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (the “Data Storage” or “Company”), today announced its intention to commence a tender offer (the “Offer”) to purchase for cash up to 6,192,990 shares of its common

CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium

CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium GlobeNewswire December 08, 2025 Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells Remarkably longer survival was observed in patients treated with leronlimab in combination with or

Scroll to Top